Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04250077 · ClinicalTrials.gov registry record · NA
We The Village Family Support Study
A NA study of Substance-Related Disorders and Family Health, sponsored by We The Village.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04250077 is a NA study of Substance-Related Disorders and Family Health that has completed, run by We The Village. The registered enrollment target is 45 participants, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04250077, a NA study of Substance-Related Disorders and Family Health, has completed, sponsored by We The Village.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The United States is in the midst of an opioid crisis. Over-prescription of opioid analgesic pain relievers contributed to a rapid escalation of use and misuse of these substances across the country. In 2016, more than 2.6 million Americans were diagnosed with opioid use disorder (OUD) and more than 42,000 have died of overdose involving opioids. This death rate is more than any year on record and has quadrupled since 1999 (1,2). Leveraging the potential of available data bases and health IT technologies may help to combat opioid crisis by targeting various aspects of the problem ranging from the prevention of opioid misuse to OUD treatment. NIH through NIDA solicits the research and development of data-driven solutions and services that focus on issues related to opioid use prevention, opioid use, opioid overdose prevention or OUD treatment. In this project, We The Village, Inc. will address a need to prepare Concerned Significant Others (CSOs) to best use their influence over the trajectory of a loved one's OUD. CSOs are motivated to help, make majority of treatment decisions and payments and have influence over treatment entry and thus, impact the trajectory of an OUD. The project goal is to develop digital delivery of Community Reinforcement And Family Training (CRAFT) methodology, an empirical family behavioral intervention to improve outcomes around treatment entry, family functioning and substance use.
Conditions Studied
Interventions
- BEHAVIORAL We The Village Peer Community Forum
- BEHAVIORAL Community Reinforcement And Family Training (CRAFT)
Study Locations (1)
New York
- We the Village, Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04250077
The ClinicalTrials.gov registry entry for NCT04250077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (97% lower). The listed sponsor is We The Village, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which We The Village Peer Community Forum is the first listed.
NCT04250077 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04250077 about?
NCT04250077 is a clinical study titled "We The Village Family Support Study". The United States is in the midst of an opioid crisis. Over-prescription of opioid analgesic pain relievers contributed to a rapid escalation of use and misuse of these substances across the country. In 2016, more than 2.6 million Americans were diagnosed with opioid use disorder (OUD) and more than...
What is the current status of trial NCT04250077?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-01-09. Estimated completion is 2020-06-30.
What conditions does trial NCT04250077 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Family Health, Community Reinforcement And Family Training.
What interventions are being tested in trial NCT04250077?
The interventions under investigation include: We The Village Peer Community Forum (BEHAVIORAL), Community Reinforcement And Family Training (CRAFT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04250077?
This trial is sponsored by We The Village, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04250077 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.